Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:48:37.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:52:44.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden screen, replacing the prior study details with an access-restricted notice. This change blocks viewing the study record and its information on this URL.
    Difference
    17%
    Check dated 2026-09-21T22:10:37.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.5 to v3.6.6, indicating a deployment/update to the site.
    Difference
    0.1%
    Check dated 2026-08-31T16:58:43.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 appears, replacing the previous v3.6.4. This indicates an update to the site's revision/version, likely a template or system change rather than content changes.
    Difference
    0.1%
    Check dated 2026-08-10T11:35:10.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4 on the page. This indicates a new version of the page template or metadata, with no substantive study details altered.
    Difference
    0.1%
    Check dated 2026-07-27T06:22:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.